Back to mobile site

BofA Securities Upgrades Rhythm Pharmaceuticals (RYTM) to Buy

August 1, 2023 1:59 PM EDT Send to a Friend
BofA Securities analyst Tazeen Ahmad upgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login